التداخل بين سيكلوفوسفاميد وريتوكسيماب

In patients with CLL, rituximab did not alter systemic exposure to fludarabine or cyclophosphamide.

In clinical trials of patients with RA, concomitant administration of methotrexate or cyclophosphamide did not alter the pharmacokinetics of rituximab.